Professional Documents
Culture Documents
Miesfeld 3/24/04
Key Concepts
- Overview of the Glycolytic Pathway
• Glycolysis generates a small amount of ATP
• Preview of the ten enzyme-catalyzed reactions of glycolysis
- Stage 1: ATP Investment
• Reaction 1: Hexokinase
• Reaction 2: Phosphoglucose isomerase
• Reaction 3: Phosphofructokinase
• Reaction 4: Aldolase
• Reaction 5: Triose phosphate isomerase
- Stage 2: ATP Earnings
• Reaction 6: Glyceraldehyde-3-P dehydrogenase
• Reaction 7: Phosphoglycerate kinase (substrate level phosphorylation)
• Reaction 8: Phosphoglycerate mutase
• Reaction 9: Enolase
• Reaction 10: Pyruvate kinase (substrate level phosphorylation)
- Regulation of the Glycolytic Pathway
• Glucokinase is a molecular sensor of high glucose levels
• Allosteric control of phosphofructokinase activity
• Supply and demand of glycolytic intermediates
- Metabolic Fate of Pyruvate
break, referring to the splitting of one molecule of glucose into two molecules of pyruvate. We will
focus on two aspects of glycolysis, 1) the enzymatic reactions that convert glucose to pyruvate,
and 2) the role of glycolysis in providing precursors, especially pyruvate, for other metabolic
pathways in humans.
Let’s begin by answering the four questions in our guidebook that pertain to glycolysis:
We first need to see where glycolysis fits into our metabolic map. As shown in figure 1, glycolysis
sits at the top of a set of four interconnected pathways that together are responsible for the
complete oxidation of glucose to CO2 and H2O by the following reaction:
2 of 25 pages
Bioc 460 - Dr. Miesfeld 3/24/04
Figure 2.
The combined reactions of glycolysis, the citrate cycle, electron transport chain and oxidative
phosphorylation, yield 32 ATP from glucose oxidation. Glycolysis alone yields only 2 ATP out of
the total 32 (6%). Therefore, it is the oxidation of pyruvate (and acetyl CoA) in the mitochondria
that generates the majority of ATP (94%) for most cells in an organism.
Figure 3.
3 of 25 pages
Bioc 460 - Dr. Miesfeld 3/24/04
The ten enzymatic reactions of glycolysis are summarized in figure 4 and involve primarily bond
rearrangements brought about by enzymes that catalyze phosphoryl transfer reactions,
isomerizations, an aldol cleavage, an oxidation, and a dehydration. There is no net loss of carbon
or oxygen atoms. Because of the requirement for ATP hydrolysis in the initial reactions, followed
by ATP synthesis in the later reactions, glycolysis is divided into two stages, Stage 1: ATP
investment (reactions 1-5) and Stage 2: ATP earnings (reactions 6-10).
Figure 4.
4 of 25 pages
Bioc 460 - Dr. Miesfeld 3/24/04
Figure 5 summarizes the glycolytic pathway showing that for every mole of glucose entering
glycolysis, two moles of glyceraldehyde-3-P are metabolized to pyruvate, and in the process,
generating a net 2 ATP and 2 NADH. The "nodes" in this wiring diagram represent metabolites in
the glycolytic pathway.Key reaction steps are highlighted along with the corresponding enzymes.
Figure 5.
One way to understand how a pathway is regulated is to examine free energy changes (ΔGº’ and
ΔG) that take place in each reaction to identify steps that are critical in driving the overall pathway
towards product formation. The free energy changes for the ten glycolytic reactions are listed in
Figure 6 including both the ΔGº’ of each reaction which is measured in the laboratory under
standard conditions, and the calculated ΔG value using ΔG = ΔGº’ +RT•ln(mass action ratio)
based on measured metabolite concentrations in erythrocytes under steady-state conditions.
Figure 6.
5 of 25 pages
Bioc 460 - Dr. Miesfeld 3/24/04
The reactions catalyzed by the enzymes hexokinase, phosphofructokinase and pyruvate kinase
have large negative ΔG values and are therefore considered irreversible reactions under
physiological conditions. Although several of the glycolytic reactions are shown to have positive
ΔG values, it is likely that the mass action ratios for these reactions do not represent actual
metabolite concentrations under conditions of high metabolic flux. A good example of this is
reaction 5 catalyzed by the enzyme triose phosphate isomerase which has an estimated ΔG of
+2.5 kJ/mol, but is nevertheless pulled to the right due to the rapid depletion of glyceraldehyde-3-P
by the highly favorable reactions in stage 2 of glycolysis. Indeed, the net ΔG value for glycolysis in
erythrocytes under steady-state conditions is overwhelmingly negative (-76.5 kJ/mol), confirming
that the glycolytic pathway is highly favorable.
Figure 8.
6 of 25 pages
Bioc 460 - Dr. Miesfeld 3/24/04
Two enzymes catalyze this phosphorylation reaction, hexokinase which is found in all cells, and
glucokinase which is present primarily in liver and pancreatic cells. Hexokinase has a broad range
of substrate specificities and also phosphorylates mannose and fructose, whereas, glucokinase is
highly specific for glucose. Hexokinase activity is inhibited by the product of the reaction, glucose-
6-P, which accumulates in cells when flux through the glycolytic pathway is restricted. As
described later, glucokinase has a much lower affinity for glucose and is not feedback inhibited by
glucose-6-P. These enzymatic properties, along with its selective expression in specific cell types,
facilitate the function of glucokinase as a metabolic “sensor” of high blood glucose levels.
Hexokinase binds glucose through an induced fit mechanism that excludes H2O from the enzyme
active site and brings the phosphoryl group of ATP into close proximity with the C6 carbon of
glucose. The molecular structure of yeast hexokinase in the presence and absence of glucose
suggests that two domains of the enzyme are like jaws that clamp down on the substrate through a
large conformational change (see figure 9). Figure 10 illustrates the induced fit mechanism of
hexokinase and also shows that glucose-6-P inhibition of hexokinase activity is mediated by
binding of glucose-6-P to an effector site in the N-terminal domain of the protein.
Figure 9.
Figure 10.
7 of 25 pages
Bioc 460 - Dr. Miesfeld 3/24/04
Figure 11.
Figure 12.
8 of 25 pages
Bioc 460 - Dr. Miesfeld 3/24/04
Figure 13.
Figure15.
The enzyme triose phosphate isomerase was introduced earlier in
the course as an example of an α/β protein structure called a TIM
barrel which was first identified in the molecular structure of triose
phosphate isomerase, thus the name TIM. As shown in figure 15,
the triose substrate sits in the enzyme active site which is formed
by the β strands and is located in the center of the protein.
9 of 25 pages
Bioc 460 - Dr. Miesfeld 3/24/04
Figure 16.
The enzyme mechanism for glyceraldehyde-3-P dehydrogenase has been worked out and is
illustrated in figure 17. Glyceraldehyde-3-P binds to the enzyme active site which contains an
associated NAD+ coenzyme molecule which will function as an electron acceptor and then reacts
with the sulfhydryl group of a cysteine residue in the enzyme active site to form a hemithioacetal
intermediate. The aldehyde group is then dehydrogenated by an oxidation reaction in which a
hydride ion (:H-) is transferred from the enzyme bound glyceraldehyde-3-P to the nicotinamide ring
of NAD+ to produce NADH, a second hydrogen is removed from the substrate and released into
solution (H+). This oxidation reaction results in the formation of a high energy enzyme-substrate
complex called a thioester intermediate which is then subject to nucleophilic attack by an incoming
phosphate ion leading to product release (1,3-bisphosphoglycerate) and regeneration of the active
enzyme.
10 of 25 pages
Bioc 460 - Dr. Miesfeld 3/24/04
Figure 17.
11 of 25 pages
Bioc 460 - Dr. Miesfeld 3/24/04
Table 18.
Figure 19.
The molecular structure of phosphoglycerate kinase is similar to hexokinase in that it has two lobes
(jaws) that each bind one of the substrates (ADP-Mg2+ or 1,3-bisphosphoglycerate) leading to a
large conformational change in the enzyme that brings the substrates close together and excludes
H2O from the active site. The structures of phosphoglycerate kinase in the open and closed
conformations are shown in figure 20.
12 of 25 pages
Bioc 460 - Dr. Miesfeld 3/24/04
Figure 20.
The bioenergetics of reaction 7 emphasize two important concepts we have presented in the
chapter. First, reaction 6 (glyceraldehyde-3-P dehydrogenase) and reaction 7 (phosphoglycerate
kinase) are coupled reactions in that the large change in standard free energy of reaction 7 (ΔGº’
= -18.9 kJ/mol) pulls the less favorable reaction 6 (ΔGº’ = +6.3 kJ/mol) to the right through the
shared intermediate 1,3-bisphosphoglcerate as shown below:
Second, the actual change in free energy for each of these two reactions is very close to zero
(ΔG = -1.3 kJ/mol, ΔG = +0.1 kJ/mol), and therefore both reactions are in fact reversible inside
the cell. Again, this difference in ΔGº’ and ΔG is due to the mass action ratio which takes into
account the actual concentrations of substrates and products that exist in the cell. Why is the
reversibility of these two reactions important? The answer is that when flux through
gluconeogenesis is high (lecture 23), these two glycolytic reactions can be reversed and thus
quickly respond to changing conditions in the cell.
13 of 25 pages
Bioc 460 - Dr. Miesfeld 3/24/04
The mechanism of this highly reversible reaction is illustrated in figure 22 where it can be seen to
require a phosphoryl transfer from a phosphorylated histidine residue (His-P) located in the
enzyme active site. In step 1, the substrate 3-phosphoglycerate binds to the enzyme active site
and is phosphorylated in the C2 position by a transfer reaction involving the His-P group. This type
of substrate interaction with the enzyme is non-covalent and referred to as a substrate•enzyme
complex. Phosphoryl transfer from the histidine residue to the C2 atom of the 3-phosphoglycerate
creates the short-lived intermediate 2,3-bisphosphoglycerate (BPG). In the second step of the
reaction, the C3 phosphate is transferred back to the histidine residue of the enzyme to regenerate
His-P, leading to the release of 2-phosphoglycerate and binding of a new molecule of 3-
phosphoglycerate in the third step. Note that the BPG formed in step 1 can diffuse out of the
active site resulting in dephosphorylated enzyme, and you may remember that in red blood cells
BPG has an important role in regulating oxygen binding to hemoglobin in red blood cells. When
BPG leaves the active site without re-phosphorylating the His group, the enzyme can only be
activated when trace amounts of BPG diffuse back into the active site.
Figure 22.
14 of 25 pages
Bioc 460 - Dr. Miesfeld 3/24/04
It is interesting that the change in standard free energy for this reaction is relatively small (ΔGº’ =
+1.7) kJ/mol), meaning that the overall metabolic energy available from 2-phosphoglycerate and
phosphoenolpyruvate is similar. However, when enolase converts 2-phosphoglycerate to
phosphoenolpyruvate, it traps the phosphate group in an unstable enol form, resulting in a
dramatic increase in the phosphoryl transfer potential of the triose sugar. The standard free
energy change for phosphate hydrolysis in 2-phosphoglycerate is ΔGº’ = -16 kJ/mol, whereas for
phosphoenolpyruvate it is an incredible ΔGº’ = -62 kJ/mol.
Figure 24.
15 of 25 pages
Bioc 460 - Dr. Miesfeld 3/24/04
Figure 25.
rates of glycolytic flux in all cells by limiting substrate availability. As suggested by the different Km
values of hexokinase and glucokinase for glucose, substrate saturation curves for these two
enzymes look markedly different as shown in figure 26. Since blood glucose levels are maintained
around 5mM, significant levels of glucose phosphorylation by glucokinase only occurs under
conditions of high glucose, such as after consuming a carbohydrate-rich meal. Moreover, since
glucokinase is not inhibited by glucose-6-P, it is able to continue functioning even if flux through
glycolysis cannot keep up with product formation.
Figure 26.
The role of glucokinase in liver cells is to trap the extra glucose that is available from the diet so
that it can be stored as glycogen for an energy source later. By being active in liver cells only when
glucose concentrations exceed normal limits (>5mM), glucokinase ensures that the liver is the
major sink for dietary glucose, and at the same time, is able to efficiently remove glucose from the
blood to help restore normal blood glucose concentrations.
17 of 25 pages
Bioc 460 - Dr. Miesfeld 3/24/04
Figure 27.
The importance of pancreatic glucokinase in insulin secretion was confirmed using transgenic mice
in which the glucokinase gene was specifically deleted in pancreatic β cells. These glucokinase-
deficient mice were defected in glucose-stimulated insulin secretion and became hyperglycemic,
eventually developing diabetic symptoms due to chronic elevated blood glucose. Well over 100
mutations in the human glucokinase gene have been identified and it is now known that a form of
type II diabetes in humans, called maturity-onset diabetes of the young (MODY2), is caused by
defects in pancreatic glucokinase activity.
18 of 25 pages
Bioc 460 - Dr. Miesfeld 3/24/04
PFK-1 is an allosteric enzyme that exists as a tetramer (a dimer of dimers) in either of two
conformations, the inactive T state or active R state, analogous to the hemoglobin tetramer. The
equilibrium between T and R states in a cell is controlled by allosteric effector molecules which
bind to a regulatory site outside of the substrate binding pocket. ATP and citrate are negative
effector molecules of PFK-1 which stabilize the T state, whereas, AMP, ADP and F-2,6-BP are
positive effector molecules that stabilize the R state. Figure 29 shows how the allosteric regulators
ATP, AMP and F-2,6-BP alter the PFK-1 reaction rate as a function of substrate concentration
(fructose-6-P).
Figure 29.
Figure 30 shows the molecular structure of PFK-1 as a monomer with reaction products fructose-
1,6-BP and ADP in the active site, and as a dimer in the active R conformation with ADP bound to
allosteric effector site. Note that the allosteric effector site is far removed from the catalytic site
and in fact maps to the interface between two PFK-1 subunits.
Figure 30.
19 of 25 pages
Bioc 460 - Dr. Miesfeld 3/24/04
Studies have shown that ATP binds with equal affinity to the catalytic site regardless of the T or R
state conformation of PFK-1. However, ATP binding to the allosteric effector site is highest when
the protein is in the T state which functions to decrease fructose-6-P binding to the catalytic site.
As illustrated in figure 31, AMP binding to the allosteric effector site serves to stabilize the R state,
and thereby stimulates the production of fructose-1,6-BP by ATP-mediated phosphoryl transfer.
This equilibrium shift between the T or R states is modulated by the energy charge of the cell such
that high ATP concentrations (high energy charge) increase the pool of PFK-1 molecules in the T
state, whereas, high AMP concentrations shifts the pool to more PFK-1 molecules in the direction
of the R state.
Figure 31.
Plants can’t make glycogen, but they do store glucose as large polymeric molecules in starch
granules. Animals that eat plants such as ourselves, break down dietary starch into the
disaccharide maltose by an enzyme in saliva called α-amylase. As shown in figure 32, maltose is
then cleaved by the enzyme maltase in the intestine to produce two molecules of glucose. Other
dietary sources of carbohydrates are the disaccharides sucrose and lactose which are cleaved by
the hydrolytic enzymes sucrase and lactase, respectively, into the monosaccharides glucose,
fructose and galactose (figure 32). Sucrose is common table sugar, and fructose is present at high
levels in many types of fruits and vegetables. Glycerol is a three carbon metabolite that is a
component of triglycerides which contain three covalently linked fatty acid molecules. A class of
hydrolytic enzymes known as lipases, cleave off the fatty acids from the triglyceride molecule to
release glycerol which can enter the glycolytic pathway. The fatty acid components of triglycerides
are metabolized in mitochondria by the fatty acid oxidation pathway to produce acetyl CoA.
20 of 25 pages
Bioc 460 - Dr. Miesfeld 3/24/04
Figure 32.
The conversion of lactose, sometimes called milk sugar, to galactose and glucose by the enzyme
lactase may be familiar to you if you are lactose-intolerant (lactose-sensitive). Individuals with
this condition experience considerable discomfort from associated intestinal symptoms (excessive
flatulence and diarrhea) when lactose-containing foods such as dairy products are eaten. The
human gene for lactase is expressed at high levels in infants to digest lactose in breast milk,
however, lactase expression normally declines in adults with the notable exception of individuals of
Scandinavian descent. The intestinal symptoms of lactose intolerance are caused by the activity of
naturally occurring anaerobic bacteria in the human intestine from the genus Lactobacillus
which ferment the undigested lactose to lactate, producing hydrogen (H2) and methane (CH4)
gases as side products. Diarrhea becomes a problem if the amount of unhydrolyzed lactose is so
high that it osmotically increases water flow into the intestine. The simplest way to prevent these
symptoms is to not eat food products containing lactose, for example, by eating soy milk products
21 of 25 pages
Bioc 460 - Dr. Miesfeld 3/24/04
rather than dairy products. Fortunately, biotechnology has provided a way to have your ice cream
and eat it too through the industrial production of purified lactase enzyme.
Fructose, galactose and glycerol enter the glycolytic pathway through a variety of routes,
many of which require additional enzymatic reactions as shown in figure 33. Glycerol for example
enters glycolysis through a two step reaction requiring the enzymes glycerol kinase and glycerol
phosphate dehydrogenase to form the glycolytic intermediate dihydroxyacetone-P. Some
metabolites enter glycolysis through a single phosphorylation reaction such as fructose in muscle
cells which is converted to fructose-6-P by the enzyme hexokinase. Fructose metabolism in liver
cells, however, is more complicated in that dietary fructose is first converted to fructose-1-P by the
enzyme fructokinase. Fructose-1-P is cleaved by fructose-1-P aldolase to generate
dihydroxyacetone-P and glyceraldehyde. Dihydroxyacetone-P is isomerized to glyceraldehyde-3-P
by the glycolytic enzyme trios phosphate isomerase, and glyceraldehyde is phosphorylated by
triose kinase to produce glyceraldehyde-3-P.
Figure 33.
22 of 25 pages
Bioc 460 - Dr. Miesfeld 3/24/04
Fructose metabolism uses the same number of invested ATP molecules as does glucose in both
muscle (1 ATP) and liver cells (2 ATP) and is a good source of dietary carbohydrate. In fact, high
fructose corn syrup is the most common added sweetener to processed foods. However, for
individuals with a genetic disease called fructose intolerance, fructose in the diet can be
extremely toxic. Fructose intolerance is due to deficiencies in the enzyme fructose-1-P
aldolase, also called aldolase B. People with fructose intolerance cannot eat foods containing
fructose because it leads to the build-up of fructose-1-P which has no alternate metabolic fates in
the absence of aldolase B. Since Pi turnover in cells is required to continually synthesize large
amounts of ATP by oxidative phosphorylation, the accumulation of fructose-1-P acts as a Pi “sink”
by tying up available phosphate in the liver that would normally be recycled by ATP hydrolysis.
Under these conditions, liver cells are quickly depleted of ATP causing ATP-dependent cation
membrane pumps to shut down, resulting in cell lysis and liver damage.
Glycolytic intermediates also serve important roles in anabolic pathways by providing
carbon skeletons for biosynthesis. Besides playing a central role in gluconeogenesis, numerous
glycolytic intermediates are used in a variety of pathways including amino acid biosynthesis, and in
the formation glycolipids and glycoproteins as illustrated in figure 34. This figure also shows that
glycolytic intermediates generate two important regulatory molecules, 2,3-bisphosphoglycerate
(BPG) and fructose-2,6-bisphosphate (F-2,6-BP), through one-step phosphorylation reactions.
Figure 34.
23 of 25 pages
Bioc 460 - Dr. Miesfeld 3/24/04
These three pyruvate pathways are responsible for regenerating the coenzyme NAD+ required to
maintain flux through the glyceraldehyde-3-P dehydrogenase reaction in glycolysis. This metabolic
requirement for NAD+ in glycolysis can be seen in individuals who have defects in the enzyme
lactate dehydrogenase, a genetic disease called lactate dehydrogenase deficiency (LDHA).
These patients cannot maintain moderate levels of exercise due to an inability to utilize glycolysis
to produce ATP needed for muscle contraction under anaerobic conditions. The lactate
dehydrogenase reaction is shown in figure 36 where it can be seen that pyruvate reduction to
24 of 25 pages
Bioc 460 - Dr. Miesfeld 3/24/04
lactate is coupled to the oxidation of NADH to produce NAD+. When lactate dehydrogenase is not
fully functional, NADH oxidation does not occur at a high enough rate to sustain glycolysis. This
causes the muscle cells to quickly run out of ATP leading to fatigue and even muscle damage if
anaerobic conditions persist. We will discuss how lactate production in athletes is normally
controlled by the liver when we look at metabolic integration in lectures 40 and 41.
Figure 36.
Substrate level phosphorylation reactions generate ATP by capturing the high phosphate transfer
potential of the substrate in a coupled reaction with ADP. The enzymes phosphoglycerate kinase
and pyruvate kinase catalyze the two substrate level phosphorylation reactions in stage 2 of
glycolysis. Since two molecules of glyceraldehyde-3-P are generated for every molecule of
glucose metabolized, each of these substrate level phosphorylation reactions yield 2ATP/glucose.
Phosphoglycerate kinase (reaction 7) provides the payback of 2ATP invested in stage 1 of
glycolysis to generate fructose-1,6-BP, whereas, reaction 10 catalyzed by pyruvate kinase
represents the ATP earnings step in the pathway by generating 2 net ATP.
Substrate availability and enzyme activity levels control glycolytic flux by regulating reaction rates.
Three of the ten glycolytic reactions are essentially irreversible under cellular conditions (ΔG<<0)
and are catalyzed by enzymes that are subject to regulation, whereas, the other seven reactions
are reversible (ΔG~0) and respond to substrate availability. Phosphofructokinase activity is
controlled by the negative allosteric effector molecules ATP and citrate which signal high energy
charge in the cell, and by the positive allosteric effector molecules ADP and F-2,6-BP which signal
low energy charge. Since phosphofructokinase is a key rate-limiting enzyme in the glycolytic
pathway, the activity level of phosphofructokinase has a major affect on glycolytic flux.
Glucokinase is subject to both types of control in that it has a low affinity for glucose and is only
active when glucose levels are high, moreover, glucokinase enzyme levels are stimulated by
glucose signaling in pancreatic b cells.